Two More Phase 3 Trials of Alzheimer ' s Drug Idalopirdine Fail Two More Phase 3 Trials of Alzheimer ' s Drug Idalopirdine Fail

Following September ' s announcement of failure in its first phase 3 trial of the drug, two more trials didn ' t reach significant efficacy and don ' t support ' regulatory submission, ' reports Lundbeck.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news